Shigella flexneri 2a Strain CVD 1207, with Specific Deletions in virG, sen, set, and guaBA, Is Highly Attenuated in Humans

A phase 1 clinical trial was conducted among 35 healthy adult volunteers to evaluate the safety, immunogenicity, and shedding of different doses of CVD 1207, a live attenuated Shigella flexneri 2a vaccine candidate with specific deletion mutations in virG, sen, set, and guaBA. CVD 1207 retains the a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kotloff, Karen L., Noriega, Fernando R., Samandari, Taraz, Sztein, Marcelo B., Losonsky, Genevieve A., Nataro, James P., Picking, William D., Barry, Eileen M., Levine, Myron M.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2000
Matèries:
Microbial Immunity and Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC97245/
https://ncbi.nlm.nih.gov/pubmed/10678904
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars